1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

  • September 2016
  • -
  • Euromonitor International
  • -
  • 30 pages

Cough, cold and allergy (hay fever) remedies witnessed 2% current value growth in 2016, to reach €226 million. As a result of global warming, the average annual temperature increased in the Netherlands. This led to more hay fever sufferers, and existing sufferers had to cope with their symptoms for longer, as they began earlier in the year. As a result sales increased due to the growing need for allergy remedies. The growth of the category was hampered by the current value stagnation in the bigg...

Euromonitor International’s Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE NETHERLANDS
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
Table 3 Sales of Decongestants by Category: Value 2011-2016
Table 4 Sales of Decongestants by Category: % Value Growth 2011-2016
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2012-2016
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2016
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Bayer Consumer Care BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 1 Bayer Consumer Care BV: Key Facts
Summary 2 Bayer Consumer Care BV: Operational Indicators
Competitive Positioning
Summary 3 Bayer Consumer Care BV: Competitive Position 2016
Omega Pharma Nederland BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 4 Omega Pharma Nederland BV: Key Facts
Summary 5 Omega Pharma Operational Indicators
Competitive Positioning
Summary 6 Omega Pharma Nederland BV: Competitive Position 2016
Remark Pharma BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 7 Remark Pharma BV: Key Facts
Summary 8 Remark Pharma BV: Key Facts
Competitive Positioning
Summary 9 Remark Pharma BV: Key Facts
Vemedia BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 10 Vemedia BV: Key Facts
Summary 11 Vemedia BV: Operational Indicators
Competitive Positioning
Summary 12 Vemedia BV: Competitive Position 2016
Executive Summary
Consumer Health Records A Positive Value Performance in 2016
the Weather Conditions Fuel Sales in Consumer Health
Companies Join Forces To Strengthen Their Positions in Consumer Health
Retail Environment Is Changing Due To Changing Consumer Patterns
Consumer Health Is Expected To Experience Moderate Value Growth Over the Forecast Period
Key Trends and Developments
Consumers Are Adopting Healthy Lifestyles
the Ageing Population in the Netherlands
A Shift in Focus Away From Treatment Towards Prevention
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 10 Life Expectancy at Birth 2011-2016
Market Data
Table 11 Sales of Consumer Health by Category: Value 2011-2016
Table 12 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 13 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 14 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format: % Value 2011-2016
Table 17 Distribution of Consumer Health by Format and Category: % Value 2016
Table 18 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 13 OTC: Switches 2014-2016
Sources
Summary 14 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Market Study on Allergic Rhinitis Treatment: Immunotherapy Treatment Segment Projected to be the Fastest Growing Segment over the Forecast Period

Global Market Study on Allergic Rhinitis Treatment: Immunotherapy Treatment Segment Projected to be the Fastest Growing Segment over the Forecast Period

  • $ 4900
  • Industry report
  • January 2017
  • by Persistence Market Research

Persistence Market Research in its recent report “Allergic Rhinitis Treatment Market: 2016–2024,” examines the global allergic rhinitis treatment market for the period of eight years. i.e. 2016-2024. ...

Allergic Rhinitis - Epidemiology Forecast To 2023

Allergic Rhinitis - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Allergic Rhinitis - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Allergic Rhinitis in seven major markets (US, France, Germany, Italy, Spain, UK and ...


Download Unlimited Documents from Trusted Public Sources

Allergy Drug Supply in Germany

  • March 2017
    3 pages
  • Allergy Drug  

    Biopharmaceutic...  

  • Germany  

View report >

Allergy Drug Industry in India

  • March 2017
    6 pages
  • Allergy Drug  

    Respiratory Dis...  

  • India  

View report >

Allergy Drug Markets in the US

  • January 2017
    18 pages
  • Allergy Drug  

  • United States  

View report >

Milk Industry

7 days ago

Related Market Segments :

Allergy Drug

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.